"The Lewis and Faye Manderson Cancer Center, a certified member of MD Anderson Cancer Network, provides advanced radiation therapy and chemotherapy."

During the past decade, DCH Cancer Treatment Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "DCH Cancer Treatment Center" #1 sponsor was "Radiation Therapy Oncology Group" with 11 trials, followed by "NRG Oncology" with 4 trials sponsored, "Acrotech Biopharma Inc." with 1 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored and "M.D. Anderson Cancer Center" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "DCH Cancer Treatment Center" #1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "Radiation Therapy Oncology Group" with 3 trials as a collaborator, "Danish Head and Neck Cancer Group" with 1 trials as a collaborator, "Eastern Cooperative Oncology Group" with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "DCH Cancer Treatment Center" are "Head and Neck Cancer" (4 trials), "Brain and Central Nervous System Tumors" (2 trials), "Lung Cancer" (2 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (2 trials) and "Adenosquamous Lung Carcinoma" (1 trials). Many other conditions were trialed in "DCH Cancer Treatment Center" in a lesser frequency.

Most popular intervention types in "DCH Cancer Treatment Center" are "Radiation" (15 trials), "Drug" (12 trials), "Procedure" (5 trials), "Biological" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (11 trials), "conventional surgery" (4 trials), "cisplatin" (3 trials), "paclitaxel" (3 trials) and "carmustine" (2 trials). Other intervention names were less common.

The vast majority of trials in "DCH Cancer Treatment Center" are 17 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "DCH Cancer Treatment Center". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in DCH Cancer Treatment Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in DCH Cancer Treatment Center, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".